pf-03084014
Showing 1 - 8 of 8
Desmoid Tumors, Aggressive Fibromatosis Trial run by the NCI (PF-03084014)
Active, not recruiting
- Desmoid Tumors
- Aggressive Fibromatosis
- PF-03084014
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 14, 2022
Tumors by Histologic Type Trial in Italy, United States (PF-03084014)
Completed
- Neoplasms by Histologic Type
- PF-03084014
-
Aurora, Colorado
- +9 more
Oct 21, 2019
Breast Cancer Metastatic Trial in Worldwide (PF-03084014, Docetaxel)
Tumor, Desmoid Tumor Trial in Aurora (PF-03084014)
No longer available
- Neoplasm
- Desmoid Tumor
- PF-03084014
-
Aurora, ColoradoUniversity of Colorado
Jan 30, 2019
Metastatic Cancer Pancreas Trial in Aurora, Rochester (PF-03084014, Gemcitabine, Nab-paclitaxel)
Terminated
- Metastatic Cancer Pancreas
- PF-03084014
- +2 more
-
Aurora, Colorado
- +4 more
Dec 20, 2018
Triple Negative Breast Tumors Trial in Worldwide (PF-03084014)
Terminated
- Triple Negative Breast Neoplasms
- PF-03084014
-
Stanford, California
- +36 more
Dec 19, 2018
Breast Cancer Trial in Belgium, France (PF-03084014, Breast cancer surgery)
Withdrawn
- Breast Cancer
- PF-03084014
- Breast cancer surgery
-
Brussels, Belgium
- +4 more
Apr 28, 2016
Advanced Solid Tumors Trial (PF-03084014)
Withdrawn
- Advanced Solid Tumors
- PF-03084014
- (no location specified)
Oct 6, 2015